The effect of prescription drug advertising on doctor visits

Journal of Economics and Management Strategy

Volumn 14, Issue 3, 2005, Pages 701-727

  Iizuka, Oshiaki ^a   Jin, Ginger Zhe ^b  

^a AOYAMA GAKUIN UNIVERSITY   (Japan)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24144498699     PISSN: 10586407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-9134.2005.00079.x     Document Type: Article

References (28)

1. Azoulay, P., 2002, "Do Pharmaceutical Sales Respond to Scientific Evidence?" Journal of Economics and Management Strategy, 11(4), 551-594.
2. Bagwell, K., 2001, The Economics of Advertising, Cheltenham, UK: Edward Elgar Publishing.
3. Berndt, E.R., L. Bui, D.R. Reiley, and G. L. Urban, 1995, "Information, Marketing, and Pricing in the US Antiulcer Drug Market," American Economic Review 85(2), 100-105.
4. Burt, C.W., 2002, "National Trends in Use of Medications in Office-Based Practice, 1985-1999" Health Affairs, 21(4), 206-214.
5. Calfee, J., C. Winston, and R. Stempski, 2002, "Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs," the Journal of Law and Economics, 45(2, pt 2), 673-690.
6. Cherry, D.K., C.W. Burt, and D.A. Woodwell, 2001, "National Ambulatory Medical Care Survey: 1999 Summary," available at www.cdc.gov.
7. FDA (Food and Drug Administration), 1999a, "Guidance for Industry: Consumer-Directed Broadcast Advertisements," available at www.fda.gov.
8. _, 1999b, "Attitudes and Behaviors Associated with Direct-to-Consumer (DTC) Promotion of Prescription Drugs Main Survey Results" available at www.fda.gov.
9. Gasmi, F., J.J. Laffont, and Q. Vuong, 1992, "Econometric Analysis of Collusive Behavior in a Soft-Drink Market," Journal of Economics and Management Strategy, 1(2), 277-311.
10. Gonul, F.F., F. Carter, and J. Wind, 2000, "What Kind of Patients and Physicians Value Direct-to-Consumer Advertising of Prescription Drugs?" Health Care Management Science, 3, 215-226.
11. _, _, E. Petrova, and K. Srinivasan, 2001, "Promotion of Prescription Drugs and Its Impact on Physicians' Choice Behavior," Journal of Marketing, 65, 79-90.
12. Hollon, M.F., 1999, "Direct-to-Consumer Marketing of Prescription Drugs," Journal of American Medical Association, 281(4), 382-384.
13. Holmer, A., 1999, "Direct-to-Consumer Prescription Drug Advertising Builds Bridges between Patients and Physicians," Journal of American Medical Association, 281(4), 380-382.
14. _, 2002, "Direct-to-Consumer Advertising: Strengthening Our Health Care System," New England Journal of Medicine, 346(7), 526-528.
15. Hurwitz, M.A. and R.E. Caves, 1988, "Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals," Journal of Law and Economics, 31 (2), 299-320.
16. Iizuka, T., 2004, "What Explains the Use of Direct-to-Consumer Advertising of Prescription Drugs?" The Journal of Industrial Economics, 52(3), 349-379.
17. _ and G. Jin, 2004, "Direct-to-Consumer Advertising and Prescription Choice," Working paper, University of Maryland, Available at http://www.glue.umd.edu/~ginger/research/choice.pdf.
18. King III, C., A.J. Silk, and N. Ketelhöhn, 2003, "Knowledge Spillovers and Growth in the Disagglomeration of the US Advertising-Agency Industry," Journal of Economics and Management Strategy, 12(3), 327-362.
19. Ling, D.C., E.R. Berndt, and M.K. Kyle, 2002, "Deregulating Direct-to-Consumer Marketing of Prescription Drugs: Effects on Prescription and Over-the-Counter Product Sales," the Journal of Law and Economics, 45(2), 691-723.
20. NIHCM (National Institute for Health Care Management Research and Educational Foundation), 2001, "Prescription Drugs and Mass Media Advertising, 2000," available at www.nihcm.org.
21. Prevention Magazine, 1998, National Survey of Consumer Reactions to Direct-to-Consumer Advertising, Emmaus, PA: Rodale Press.
22. Rizzo, J.A., 1999, "Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs," Journal of Law and Economics, 42(1), 89-116.
23. Roberts, M.J. and L. Samuelson, 1988, "An Empirical Analysis of Dynamic, Nonprice Competition in an Oligopolistic Industry," Rand Journal of Economics, 19(2), 200-220.
24. Rosenthal, M.B., E.R. Berndt, J.M. Donohue, and R.G. Frank, 2002, "Promotion of Prescription Drugs to Consumers," New England Journal of Medicine, 346(7), 498-505.
25. _, _, _, A.M. Epstein, and R.G. Frank, 2003, "Demand Effects of Recent Changes in Prescription Drug Promotion,"D. M. Cutler and A. M. Garber, eds. Frontiers in Health Policy Research, vol. 6, Cambridge, MA: The MIT Press, 1-26.
26. Wolfe, S.M., 2002, "Direct-to-Consumer Advertising: Education or Emotion Promotion?" New England Journal of Medicine, 346(7), 524-526.
27. Wooldridge, J.M., 2002, Econometric Analysis of Cross Section and Panel Data, Cambridge, MA: MIT Press.
28. Wosinska, M., 2002, "Just What the Patient Ordered? Direct-to-Consumer Advertising and the Demand for Pharmaceutical Products," Harvard Business School Marketing Research Paper Series, No. 02-04.